Ardian, Keensight Capital and Parquest Capital complete the acquisition of Unither, alongside its management, from Equistone Partners Europe

▤ Summary

Ardian, Keensight Capital, and Parquest Capital have completed their acquisition of Unither alongside management. Unither is a pharmaceutical CDMO that develops and manufactures easy-to-use dosage form solutions and leads the market in blow-fill-seal technology. The new owners plan to support Unither’s global growth across Europe, the United States, South America, and eventually Asia. They also intend to consider further acquisition opportunities as part of the company’s expansion strategy.

▦ Linked Companies